<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> that characterizes the development of <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo>-associated <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> is a multi-step process in which genetic alterations in various <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated genes accumulate </plain></SENT>
<SENT sid="1" pm="."><plain>Defective mismatch repair (MMR) is the cause of microsatellite instability (MSI) pathway that characterizes a subset of <z:e sem="disease" ids="C0017185" disease_type="Neoplastic Process" abbrv="">gastrointestinal tumors</z:e> and is specifically associated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development within the <z:e sem="disease" ids="C1333990" disease_type="Neoplastic Process" abbrv="">hereditary nonpolyposis colorectal cancer</z:e> (HNPCC) syndrome </plain></SENT>
<SENT sid="2" pm="."><plain>The few studies that have assessed MMR defects in Barrett-associated <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> have reached different results </plain></SENT>
<SENT sid="3" pm="."><plain>We therefore assessed the expression of the MMR proteins MLH1 and MSH2 in a series of 59 Barrett <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> and found a loss of MMR protein immunostaining in 2/59 (3%) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>; one <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> showed a loss of MSH2 expression, the other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> showed a loss of MLH1, and both <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> displayed an MSI-high phenotype </plain></SENT>
<SENT sid="4" pm="."><plain>Our findings suggest that only a small subset of Barrett <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> develop because of defective MMR, but demonstrate that MLH1 and MSH2 are the primary targets for defective MMR also in this <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> type </plain></SENT>
</text></document>